These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27067743)

  • 1. Role of Digoxin in Atrial Fibrillation.
    Scalese MJ; Salvatore DJ
    J Pharm Pract; 2017 Aug; 30(4):434-440. PubMed ID: 27067743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure.
    Bavendiek U; Aguirre Davila L; Koch A; Bauersachs J
    Eur Heart J; 2017 Jul; 38(27):2095-2099. PubMed ID: 28065909
    [No Abstract]   [Full Text] [Related]  

  • 3. A Comprehensive Review on Unveiling the Journey of Digoxin: Past, Present, and Future Perspectives.
    Khandelwal R; Vagha JD; Meshram RJ; Patel A
    Cureus; 2024 Mar; 16(3):e56755. PubMed ID: 38650769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should We Stop Prescribing Digoxin?
    Rattanawong P; Heist EK
    JACC Clin Electrophysiol; 2024 May; ():. PubMed ID: 38842976
    [No Abstract]   [Full Text] [Related]  

  • 5. Digoxin: The good and the bad.
    Ziff OJ; Kotecha D
    Trends Cardiovasc Med; 2016 Oct; 26(7):585-95. PubMed ID: 27156593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin for Worsening Chronic Heart Failure: Underutilized and Underrated.
    Ambrosy AP; Pang PS; Gheorghiade M
    JACC Heart Fail; 2016 May; 4(5):365-7. PubMed ID: 27126283
    [No Abstract]   [Full Text] [Related]  

  • 7. Digoxin and Mortality in Patients With Atrial Fibrillation.
    Lopes RD; Rordorf R; De Ferrari GM; Leonardi S; Thomas L; Wojdyla DM; Ridefelt P; Lawrence JH; De Caterina R; Vinereanu D; Hanna M; Flaker G; Al-Khatib SM; Hohnloser SH; Alexander JH; Granger CB; Wallentin L;
    J Am Coll Cardiol; 2018 Mar; 71(10):1063-1074. PubMed ID: 29519345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin in Atrial Fibrillation: An Old Topic Revisited.
    Ferrari F; Santander IRMF; Stein R
    Curr Cardiol Rev; 2020; 16(2):141-146. PubMed ID: 31237216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin: Pharmacology and toxicology-A review.
    Patocka J; Nepovimova E; Wu W; Kuca K
    Environ Toxicol Pharmacol; 2020 Oct; 79():103400. PubMed ID: 32464466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.
    Sethi NJ; Safi S; Feinberg J; Nielsen EE; Gluud C; Jakobsen JC
    Syst Rev; 2017 Apr; 6(1):71. PubMed ID: 28381269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin.
    Aronson JK
    Contemp Issues Clin Biochem; 1985; 3():182-210. PubMed ID: 3915966
    [No Abstract]   [Full Text] [Related]  

  • 13. Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 Trial.
    Eisen A; Ruff CT; Braunwald E; Hamershock RA; Lewis BS; Hassager C; Chao TF; Le Heuzey JY; Mercuri M; Rutman H; Antman EM; Giugliano RP
    J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28666993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate control in atrial fibrillation.
    Van Gelder IC; Rienstra M; Crijns HJ; Olshansky B
    Lancet; 2016 Aug; 388(10046):818-28. PubMed ID: 27560277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A patient with severe digoxin toxicity].
    van Rhee KP; van Bentum R; van Keulen K; Kuypers MI; Haak MB
    Ned Tijdschr Geneeskd; 2017; 161():D839. PubMed ID: 28224871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of digoxin on mortality in patients with chronic systolic heart failure: A propensity-matched cohort study.
    Al-Khateeb M; Qureshi WT; Odeh R; Ahmed AM; Sakr S; Elshawi R; Bdeir MB; Al-Mallah MH
    Int J Cardiol; 2017 Feb; 228():214-218. PubMed ID: 27865188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Digoxin and atrial fibrillation in 2016].
    Théone S; Carballo S; Carballo D; Marti C
    Rev Med Suisse; 2016 Oct; 12(535):1758-1760. PubMed ID: 28692216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.
    Kotecha D; Calvert M; Deeks JJ; Griffith M; Kirchhof P; Lip GY; Mehta S; Slinn G; Stanbury M; Steeds RP; Townend JN
    BMJ Open; 2017 Jul; 7(7):e015099. PubMed ID: 28729311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Digoxin].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1988 Jul; 132(28):1276-80. PubMed ID: 3043235
    [No Abstract]   [Full Text] [Related]  

  • 20. Digoxin Use and Associated Adverse Events Among Older Adults.
    Angraal S; Nuti SV; Masoudi FA; Freeman JV; Murugiah K; Shah ND; Desai NR; Ranasinghe I; Wang Y; Krumholz HM
    Am J Med; 2019 Oct; 132(10):1191-1198. PubMed ID: 31077654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.